Main: 815.398.9491 | Ortho Express: 779 .771.7000

Research Center

OrthoIllinois has long held a commitment to continuing medical education and providing university-level care, so in 2006 it was a natural next step to formalize a program that allows our physicians to participate in the process that contributes to medical research and makes revolutionary new products and treatments possible.

BE A PART OF OUR CLINICAL STUDIES:

Current studies:

If interested, please call Lisa at 815-847-7078.

  • OSTEOARTHRITISDr. David Dansdill, Rheumatologist at OrthoIllinois in Rockford
    • A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee.
    • MD conducting the study: Dr. Dansdill
    • If interested, call Kate at 815-484-6942

 

 

  • RHEUMATOID ARTHRITISDr. Richard Olson, Rheumatologist at OrthoIllinois in Rockford
    • Collect and document use patterns, effectiveness, and safety of all treatments currently used in the management of rheumatoid arthritis which will be maintained in a national database, the Consortium of Rheumatology Researchers of North America (CORRONA), for purposes related to drug safety, clinical outcomes and market research.
    • MD conducting the study: Dr. Olson
    • If interested, please call Kate at 815-484-6942

 

  • ROTATOR CUFF TEARDr. Scott Trenhaile, Sports Medicine orthopedic surgeon at OrthoIllinois in Rockford
    • A Prospective, Single Blinded, Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Effectiveness of the InSpace™ Device for Treatment of Full Thickness Massive Rotator Cuff Tears.  http://rotationmedical.com/rotation-medical-solution/
    • MD conducting the study: Dr. Trenhaile
    • If interested, please call Lisa at 815-847-7078

 

  • ROTATOR CUFF TEARDr. Scott Trenhaile, Sports Medicine orthopedic surgeon at OrthoIllinois in Rockford
    • A Prospective, Non-Randomized, Post Market study to assess the effectiveness of the Rotation Medical Bioinductive Implant used in the treatment of supraspinatus tendon tears. http://rotationmedical.com/rotation-medical-solution/
    • MD conducting the study: Dr. Trenhaile
    • If interested, please call Gaby at 815-381-7457

 

  • CARTILAGE REPAIR OF THE KNEEDr. Geoffrey Van Thiel, sports medicine orthopedic surgeon at OrthoIllinois, Crystal Lake, Rockford, Huntley
    • MD conducting the study: Dr. Van Thiel
    • If interested, please call Gaby at 815-381-7457.
    • A prospective, randomized, active treatment-controlled, evaluator-blinded study to evaluate the Hylofast® device with autologous BMAC in the treatment of articular knee cartilage defect lesions in comparison to microfracture treatment.

Upcoming studies:

 

About Clinical Research:

Clinical research studies are biomedical or health-related studies that involve patients with a targeted diagnosis. Depending on the specific study, there are usually 50-100 sites nationally or internationally participating in a particular study. Sites are carefully selected based on state-of-the-art diagnostic and facility criteria and by the commitment demonstrated by the physicians involved in top quality patient care.

By participating in national and international clinical research studies at the Phase II-IV levels, OrthoIllinois physicians have access to new treatment options for patients on a local level who have not experienced improvement through other treatments.

Since opening the research center at OrthoIllinois, the practice has been involved in 80 clinical research and device studies. We are proud to have participated in the first in class drug studies for the treatment of rheumatoid arthritis, notably Xejanz® and Otezla®, as well as state-of-the-art medical device studies for hip replacement and shoulder tears and using the body’s own stem cells to heal joint damage.  OrthoIllinois’ involvement in clinical research studies allows the physicians to stay on the cutting edge of new treatment options. As these new medications are approved by the FDA for mainstream use, OrthoIllinois physicians are already familiar with and comfortable using them due to involvement in the studies.

Involvement in these studies offers great benefits to patients as well as expanding the physicians’ knowledge. Study participants gain access to new research treatments before they are FDA approved or available and have a more active role in their health care.

Participating in a research study offers financial as well as health benefits, especially for those with high co-pays or who do not have healthcare coverage. All laboratory, medication, and physician costs are covered for the patient participant by the company conducting the study.

For further information about research studies contact Lisa Foti, MS, Director of Research at 815-847-7078.

For more information:

Contact or Call
  • This field is for validation purposes and should be left unchanged.
© OrthoIllinois, formerly known as Rockford Orthopedic Associates 2017